Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
Research output: Contribution to journal › Journal article › Research › peer-review
The lowering of cholesterol concentrations in individuals at high risk of cardiovascular disease improves outcome. No study, however, has assessed benefits of cholesterol lowering in the primary prevention of coronary heart disease (CHD) in hypertensive patients who are not conventionally deemed dyslipidaemic.
| Original language | English |
|---|---|
| Journal | Lancet |
| Volume | 361 |
| Issue number | 9364 |
| Pages (from-to) | 1149-58 |
| Number of pages | 10 |
| ISSN | 0140-6736 |
| DOIs | |
| Publication status | Published - 5 Apr 2003 |
ID: 34079207